Document is current
Any future updates will be listed below
-
Authors
Omezzolli, Giulia
Iannello, Andrea
Vallone, Francesco E.
Brandimarte, Lorenzo
Micillo, Matilde
Bertola, Nadia
Lavarello, Chiara
Grinovero, Nicole
Ferrero, Giulio
Mellert, Kevin
Möller, Peter
Bruno, Silvia
Furman, Richard R.
Allan, John N.
Petretto, Andrea
Deaglio, Silvia
Ravera, Silvia
Vaisitti, Tiziana https://orcid.org/0000-0002-3375-6985
-
Funding
Funding for this research was provided by:
Università degli Studi di Torino
- License Information
-
More Information
Article History
Received: 14 November 2024
Revised: 25 February 2025
Accepted: 19 March 2025
First Online: 9 April 2025
Declarations
:
: S.D. has research grants from AstraZeneca and Solve Therapeutics. The remaining authors declare no competing financial interests.
: The Institutional Animal Care and Use Committee approved all the experiments involving mice. Mice were treated following the European guidelines and with the approval of the Italian Ministry of Health (authorization #664/2020-PR).
: Not applicable to the present study.
: Authors’ sources of funding, and financial or non-financial interests are stated above.
